Literature DB >> 22632863

Rikkunshito and ghrelin secretion.

Hiroshi Takeda1, Shuichi Muto, Koji Nakagawa, Shunsuke Ohnishi, Masahiro Asaka.   

Abstract

Rikkunshito is a kampo herbal medicine which is widely used in Japan for the treatment of the upper gastrointestinal symptoms of patients with functional dyspepsia (FD), gastroesophageal reflux disease (GERD), dyspeptic symptoms of postgastrointestinal surgery patients, and chemotherapy-induced dyspepsia in cancer patients. Recently, very unique characteristics of rikkunshito have been unveiled; oral administration of rikkunshito potentiates orexigenic action of ghrelin through several different mechanisms. In addition, several lines of evidence obtained from both animal and human studies indicate that rikkunshito can be an attractive and promising therapeutic option for the anorectic conditions including cisplatin-induced dyspepsia, anorexia of aging, stress-induced hypophagia, cancer cachexia-anorexia syndrome. In this review, we will highlight what is known about the orexigenic effect of rikkunshito with a special focus on an interaction with ghrelin signaling system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632863     DOI: 10.2174/138161212803216933

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy.

Authors:  Tomoharu Yoshiya; Takahiro Mimae; Masaoki Ito; Shinsuke Sasada; Yasuhiro Tsutani; Kenichi Satoh; Takeshi Masuda; Yoshihiro Miyata; Noboru Hattori; Morihito Okada
Journal:  Invest New Drugs       Date:  2019-08-19       Impact factor: 3.850

2.  Effect of rikkunshi-to treatment on chemotherapy-induced appetite loss in patients with lung cancer: A prospective study.

Authors:  Takako Oteki; Asuka Ishikawa; Yoshie Sasaki; Gen Ohara; Katsunori Kagohashi; Koichi Kurishima; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2015-11-27       Impact factor: 2.447

Review 3.  Management of functional dyspepsia: state of the art and emerging therapies.

Authors:  Hiroshi Yamawaki; Seiji Futagami; Mako Wakabayashi; Noriko Sakasegawa; Shuhei Agawa; Kazutoshi Higuchi; Yasuhiro Kodaka; Katsuhiko Iwakiri
Journal:  Ther Adv Chronic Dis       Date:  2017-08-27       Impact factor: 5.091

Review 4.  Role of ghrelin in the pathophysiology of gastrointestinal disease.

Authors:  Cynthia K Cheung; Justin Che-Yuen Wu
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

5.  Kampo medicine for palliative care in Japan.

Authors:  Hirokuni Okumi; Atsuko Koyama
Journal:  Biopsychosoc Med       Date:  2014-01-22

Review 6.  Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome.

Authors:  Naoki Fujitsuka; Yasuhito Uezono
Journal:  Front Pharmacol       Date:  2014-12-10       Impact factor: 5.810

Review 7.  The Role of Ghrelin and Ghrelin Signaling in Aging.

Authors:  Marie Amitani; Haruka Amitani; Kai-Chun Cheng; Timothy Sean Kairupan; Nanami Sameshima; Ippei Shimoshikiryo; Kimiko Mizuma; Natasya Trivena Rokot; Yasuhito Nerome; Tetsuhiro Owaki; Akihiro Asakawa; Akio Inui
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

8.  Pilot quasi-randomized controlled study of herbal medicine Hochuekkito as an adjunct to conventional treatment for progressed pulmonary Mycobacterium avium complex disease.

Authors:  Yasunori Enomoto; Eri Hagiwara; Shigeru Komatsu; Ryuichi Nishihira; Tomohisa Baba; Hideya Kitamura; Akimasa Sekine; Atsuhito Nakazawa; Takashi Ogura
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.